DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.
Nokia Power Up? Bets On Network Boom And Share Buyback After Rocky 2023
Nokia Corporation has announced its expectation for growth in network infrastructure in the latter half of 2024 and revealed a €600 million share repurchase plan over two years, despite facing a challenging 2023 with reduced net income and revenue.
